https://vital.seals.ac.za/vital/access/manager/Index ${session.getAttribute("locale")} 5 https://vital.seals.ac.za/vital/access/manager/Repository/vital:6385 Wed 12 May 2021 20:37:04 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6445 Wed 12 May 2021 20:17:28 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6356 0.95) was noted for both methods of assessment. The chromameter ED[subscript 50] values determined in this study were approximately 2 hours for both preparations. At this dose duration the instrument would not be sensitive enough to distinguish between weak blanching responses and normal skin for bioequivalence assessment purposes.]]> Wed 12 May 2021 20:14:50 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6381 Wed 12 May 2021 19:07:40 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6408 Wed 12 May 2021 19:05:50 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6444 209.00 and 205.00 > 161.00, respectively. Calibration curves were linear over the range 0.5–500 ng/ml with correlation coefficients > 0.999. The accuracy and precision of the method were found to be between 99.97% and 104.67% (R.S.D. < 2%) and the mean recovery of KET from normal saline was 88.03 ± 0.3% (R.S.D. < 2.20%). The LLOQ and LOD values were found to be 0.5 and 0.1 ng/ml respectively whereas the ULOD was set at 500 ng/ml. The method was successfully applied to determine the bioavailability of KET following application of topical KET gel, Fastum® gel, to the skin of human volunteers.]]> Wed 12 May 2021 18:49:51 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6400 Wed 12 May 2021 18:33:39 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:7011 Wed 12 May 2021 18:24:35 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6360 Wed 12 May 2021 18:24:11 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6417 Wed 12 May 2021 18:04:06 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6361 Wed 12 May 2021 17:18:51 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6406 Wed 12 May 2021 17:15:47 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6388 Wed 12 May 2021 16:51:06 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:3849 Wed 12 May 2021 16:29:13 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6374 Wed 12 May 2021 16:12:28 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:44194 Thu 19 Aug 2021 14:23:27 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6357 -cyclodextrin concentrations were investigated. A polyimide fused-silica square capillary column (75 μm I.D. × 360 μm O.D.) with a total length of 60.0 cm and effective length of 45.0 cm was used for the separation. The final BGE consisted of 20 mM phosphoric acid, 40 mM SDS and 12 mM -cyclodextrin (pH 2.2) using reverse polarity with a voltage of −17.5 kV. Samples were injected electrokinetically at −5 kV for 3 s for the qualitative analysis and hydrodynamically at 20 mbar for 0.6 s for the quantitative assay. The total run time was 22 min and the limits of detection were 3.13 μg/ml and 1.88 μg/ml for rutin and quercetin, respectively. Fingerprint profiles of the solid oral dosage forms and the results of the quantitative analysis indicated that there were major discrepancies in the marker content between products and illustrates the value of this method for use as a procedure to assess product quality of commercially available Ginkgo biloba products.]]> Thu 15 Jul 2021 21:30:37 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6393 Thu 15 Jul 2021 21:30:36 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6397 Thu 15 Jul 2021 21:30:36 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6396 Thu 15 Jul 2021 21:30:35 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6350 Thu 15 Jul 2021 21:30:34 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6430 Thu 15 Jul 2021 21:23:34 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6401 Thu 15 Jul 2021 21:23:34 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6428 Thu 15 Jul 2021 21:23:34 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6429 Thu 15 Jul 2021 21:23:34 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6398 Thu 13 May 2021 08:13:33 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6423 Thu 13 May 2021 07:43:38 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6376 Thu 13 May 2021 07:39:12 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:38888 Thu 13 May 2021 07:29:26 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6382 Thu 13 May 2021 07:14:28 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6375 Thu 13 May 2021 06:48:19 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6363 Thu 13 May 2021 02:03:39 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6364 Thu 13 May 2021 00:56:56 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6399 Thu 13 May 2021 00:28:45 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6452 Thu 13 May 2021 00:14:01 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:6421 Thu 13 May 2021 00:03:40 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:44214 Fri 20 Aug 2021 13:20:03 SAST ]]>